Long-term treatment may continue for years with ongoing monitoring, though some patients may eventually discontinue with appropriate support for weight maintenance
For someone on tirzepatide who is already dealing with body aches , reduced caloric intake, and potential muscle loss, adding anemia to the mix would be counterproductive
& Petri, M
The peptide mechanisms of action are not gender-specific, and the safety profile appears comparable across genders
Describe the specific symptoms you're experiencing, their severity, timing in relation to doses, and impact on daily functioning
Similar to Mounjaro, there is a potential for cost reduction in the future, driven by generic drug alternatives following patent expirations